Martinez-Picado J - Search Results

1

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Bernal S, Puertas MC, Morón-López S, Cranston RD, Urrea V, Dalmau J, Salgado M, Gálvez C, Erkizia I, McGowan I, Scherrer D, Revollo B, Sirera G, Santos JR, Clotet B, Paredes R, Martinez-Picado J. Bernal S, et al. Among authors: martinez picado j. J Infect Dis. 2023 Nov 2;228(9):1280-1291. doi: 10.1093/infdis/jiad251. J Infect Dis. 2023. PMID: 37395474 Free PMC article.

2

Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load.

Arnó A, Ruiz L, Juan M, Jou A, Balagué M, Zayat MK, Marfil S, Martínez-Picado J, Martínez MA, Romeu J, Pujol-Borrell R, Lane C, Clotet B. Arnó A, et al. J Infect Dis. 1999 Jul;180(1):56-60. doi: 10.1086/314831. J Infect Dis. 1999. PMID: 10353861 Clinical Trial.

3

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression.

Ruiz L, Martinez-Picado J, Romeu J, Paredes R, Zayat MK, Marfil S, Negredo E, Sirera G, Tural C, Clotet B. Ruiz L, et al. AIDS. 2000 Mar 10;14(4):397-403. doi: 10.1097/00002030-200003100-00013. AIDS. 2000. PMID: 10770542

4

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.

Ruiz L, Carcelain G, Martínez-Picado J, Frost S, Marfil S, Paredes R, Romeu J, Ferrer E, Morales-Lopetegi K, Autran B, Clotet B. Ruiz L, et al. AIDS. 2001 Jun 15;15(9):F19-27. doi: 10.1097/00002030-200106150-00001. AIDS. 2001. PMID: 11416734 Clinical Trial.

5

[Resistance to protease inhibitors].

Clotet B, Martínez-Picado J, Arrizabalaga J, Ruiz L. Clotet B, et al. Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):34-41. Enferm Infecc Microbiol Clin. 2001. PMID: 11428058 Review. Spanish. No abstract available.

6

Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.

Frost SD, Martinez-Picado J, Ruiz L, Clotet B, Brown AJ. Frost SD, et al. J Virol. 2002 Feb;76(3):968-79. doi: 10.1128/jvi.76.3.968-979.2002. J Virol. 2002. PMID: 11773372 Free PMC article.

7

Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.

Martinez-Picado J, Morales-Lopetegi K, Wrin T, Prado JG, Frost SD, Petropoulos CJ, Clotet B, Ruiz L. Martinez-Picado J, et al. AIDS. 2002 Apr 12;16(6):895-9. doi: 10.1097/00002030-200204120-00009. AIDS. 2002. PMID: 11919491

8

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.

Prado JG, Wrin T, Beauchaine J, Ruiz L, Petropoulos CJ, Frost SD, Clotet B, D'Aquila RT, Martinez-Picado J. Prado JG, et al. AIDS. 2002 May 3;16(7):1009-17. doi: 10.1097/00002030-200205030-00007. AIDS. 2002. PMID: 11953467

9

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.

Clotet B, Ruiz L, Martinez-Picado J, Negredo E, Hill A, Popescu M. Clotet B, et al. HIV Clin Trials. 2002 Jul-Aug;3(4):316-23. doi: 10.1310/67te-gpxq-r1lb-bpkg. HIV Clin Trials. 2002. PMID: 12187506

10

Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.

Martinez-Picado J, Frost SD, Izquierdo N, Morales-Lopetegi K, Marfil S, Puig T, Cabrera C, Clotet B, Ruiz L. Martinez-Picado J, et al. J Virol. 2002 Dec;76(23):12344-8. doi: 10.1128/jvi.76.23.12344-12348.2002. J Virol. 2002. PMID: 12414975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page